ProfileGDS4718 / 218186_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 96% 72% 96% 95% 94% 95% 97% 96% 96% 97% 96% 98% 94% 96% 96% 97% 96% 97% 93% 97% 96% 97% 97% 96% 97% 97% 93% 97% 96% 98% 97% 97% 97% 98% 96% 96% 97% 97% 31% 98% 96% 94% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.101797
GSM549102patient 115, normal, homogenized [OPG study]10.686296
GSM549104patient 119, normal, homogenized [OPG study]7.1469472
GSM549108patient 138, normal, homogenized [OPG study]10.598196
GSM549119patient 077, normal, homogenized [OPG study]10.451695
GSM549133patient 032, cancer, homogenized [OPG study]10.049994
GSM549139patient 042, cancer, homogenized [OPG study]10.117395
GSM549099patient 107, normal, homogenized [OPG study]10.962797
GSM549109patient 139, normal, homogenized [OPG study]10.782196
GSM549110patient 046, normal, homogenized [OPG study]10.851896
GSM549114patient 063, normal, homogenized [OPG study]11.162797
GSM549122patient 082, normal, homogenized [OPG study]10.499196
GSM549134patient 033, cancer, homogenized [OPG study]11.290898
GSM549136patient 036, cancer, homogenized [OPG study]9.9756594
GSM549140patient 044, cancer, homogenized [OPG study]10.457196
GSM549111patient 047, normal, homogenized [OPG study]10.765496
GSM549113patient 057, normal, homogenized [OPG study]11.242197
GSM549132patient 031, cancer, homogenized [OPG study]10.293896
GSM549137patient 038, cancer, homogenized [OPG study]10.885897
GSM549142patient 047, cancer, homogenized [OPG study]9.3129993
GSM549100patient 110, normal, homogenized [OPG study]10.792997
GSM549107patient 135, normal, homogenized [OPG study]10.662196
GSM549115patient 068, normal, homogenized [OPG study]11.180897
GSM549116patient 072, normal, homogenized [OPG study]11.04997
GSM549120patient 078, normal, homogenized [OPG study]10.551296
GSM549131patient 030, cancer, homogenized [OPG study]10.903397
GSM549118patient 074, normal, homogenized [OPG study]10.963997
GSM549129patient 027, cancer, homogenized [OPG study]9.6679793
GSM549123patient 088, normal, homogenized [OPG study]11.241497
GSM549124patient 006, cancer, homogenized [OPG study]10.341496
GSM549126patient 015, cancer, homogenized [OPG study]11.162198
GSM549128patient 025, cancer, homogenized [OPG study]10.747797
GSM549103patient 117, normal, homogenized [OPG study]10.903797
GSM549117patient 073, normal, homogenized [OPG study]11.399297
GSM549138patient 041, cancer, homogenized [OPG study]11.317598
GSM549141patient 045, cancer, homogenized [OPG study]10.496796
GSM549130patient 028, cancer, homogenized [OPG study]10.342196
GSM549101patient 111, normal, homogenized [OPG study]10.827397
GSM549105patient 128, normal, homogenized [OPG study]10.828397
GSM549106patient 134, normal, homogenized [OPG study]4.5412131
GSM549112patient 048, normal, homogenized [OPG study]11.497798
GSM549125patient 011, cancer, homogenized [OPG study]10.360196
GSM549127patient 024, cancer, homogenized [OPG study]9.7635794
GSM549135patient 035, cancer, homogenized [OPG study]10.481796